Merck Trials Manufacturing Agreement With China’s Huahai Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Zhejiang Huahai Pharmaceutical and Merck have entered into a trial manufacturing services agreement, the Chinese firm announced
You may also be interested in...
Merck Expands Outsourcing With Zhejiang Huahai For HIV Finished Product Manufacturing
Deal will create $20 million in annual revenue over five years for the company, an analyst projects.
Merck Expands Outsourcing With Zhejiang Huahai For HIV Finished Product Manufacturing
Deal will create $20 million in annual revenue over five years for the company, an analyst projects.
Merck Expands Outsourcing With Zhejiang Huahai For HIV Finished Product Manufacturing
SHANGHAI - China's leading contract manufacturing company and API provider Zhejiang Huahai announced March 8 that the company has reached a drug supply agreement with Merck to produce finished drugs for the next several years